Role of phosphatidylinositol 3-kinase/Akt pathway in angiotensin II and insulin-like growth factor-1 modulation of nitric oxide synthase in vascular smooth muscle cells

被引:0
作者
Esma R. Isenovic
Yong Meng
Andras Divald
Nikola Milivojevic
James R. Sowers
机构
[1] SUNY-Health Science Center,Department of Biochemistry
[2] SUNY-Health Science Center,Department of Cell Biology
[3] SUNY-Health Science Center,Department of Medicine
[4] SUNY-Health Science Center,Department of Pediatrics
[5] VA Medical Center,undefined
来源
Endocrine | 2002年 / 19卷
关键词
Angiotensin II; nitric oxide synthase; insulin-like growth factor-1; phosphatidylinositol 3-kinase; Akt; vascular smooth muscle cells;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of this study was to examine the role of the phosphatidylinositol 3-kinase (PI3K)/serine/threonine kinase Akt signaling pathway in mediating interactions between angiotensin II (Ang II) and insulin-like growth factor-1 (IGF-1) in regulation of inducible nitric oxide synthase (iNOS) in vascular smooth muscle cells (VSMCs). Exposure to 100 nMIGF-1 for 10 min resulted in increased insulin-receptor substrate-1 associated PI3K activity and Akt kinase activity, whereas 100 nM Ang II pretreatment for 5 min strikingly decreased these IGF-1 effects. NOS activity was also increased in VSMCs following exposure to IGF-1 (10 min up to 24 h). Pretreatment with Ang II for 5 min reduced IGF-1-induced NOS activity. IGF-1 treatment for 24 hr increased iNOS gene transcription, and Ang II pretreatment reduced this stimulation of iNOS gene expression by attenuating PI3K/Akt signaling. These results implicate PI3K/Akt pathways in Ang II/IGF-1 regulation of iNOS in VSMCs.
引用
收藏
页码:287 / 291
页数:4
相关论文
共 102 条
  • [1] Sowers J. R.(1997)undefined Hypertension 29 691-699
  • [2] Khorsandi M. J.(1992)undefined J. Clin. Invest. 90 1926-1931
  • [3] Fagin J. A.(1993)undefined J. Biol. Chem. 268 16866-16870
  • [4] Giannella-Neto D.(1998)undefined N. Engl. J. Med. 336 633-640
  • [5] Forrester J. S.(1996)undefined Cell 85 695-705
  • [6] Cercek B.(1999)undefined J. Biol. Chem. 274 8347-8350
  • [7] Delafontaine P.(2000)undefined J. Clin. Invest. 106 493-499
  • [8] Lou H.(1995)undefined Cell 81 727-736
  • [9] LeRoith D.(2000)undefined Circulation 101 1539-1545
  • [10] Eck M. J.(1998)undefined Biochim. Biophys. Acta 1436 127-150